Evidence-gap map · non-drug interventions

Pulmonary Arterial Hypertension evidence gaps

173 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Pulmonary Arterial Hypertension

Which non-drug approaches have been tested for Pulmonary Arterial Hypertension, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

173registered non-drug trials
16with results posted
23recruiting as of 2026-11-16
76group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Pulmonary Arterial Hypertension by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (53)2·11·129924231·101 with results11
Rehabilitation and therapy services (13)······8·11111·31 with results·
Breathing and respiratory training (18)1····19352·1··14
Mind-body and psychological approaches (6)1··31 with results··111···22 with results·11 with results·
Cognitive training and education (14)···1··21 with results41 with results····2·51 with results31 with results
Diet, fasting and nutrition (3)········11···11 with results··
Sleep and circadian approaches (6)·····1·21······2
Neuromodulation and electrical stimulation (2)······211·······
Oxygen, light, temperature and manual therapies (17)2·1···291··2··11 with results3
Supplements and nutraceuticals (15)··11 with results···3111142 with results··21 with results51 with results
Other devices and digital tools (3)······2········1
Care delivery and health services (4)·······11 with results·····41 with results··
Other behavioural, not yet classified (29)···1·16102 with results431 with results31 with results·22 with results131 with results5

The table scrolls sideways: 16 outcome columns.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 13 trials of rehabilitation and therapy services found, none used heart rate, blood pressure and autonomic as a primary outcome (39 trials of other approaches did).
  • Among the 14 trials of cognitive training and education found, none used breathing and lung function as a primary outcome (17 trials of other approaches did).
  • Among the 14 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (11 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (10 trials of other approaches did).
  • Among the 14 trials of cognitive training and education found, none used quality of life as a primary outcome (10 trials of other approaches did).
  • Among the 18 trials of breathing and respiratory training found, none used weight and metabolic markers as a primary outcome (7 trials of other approaches did).
  • Among the 18 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (7 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used weight and metabolic markers as a primary outcome (7 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used symptom severity and disease activity as a primary outcome (7 trials of other approaches did).
  • Among the 15 trials of supplements and nutraceuticals found, none used symptom severity and disease activity as a primary outcome (7 trials of other approaches did).
  • Among the 14 trials of cognitive training and education found, none used weight and metabolic markers as a primary outcome (7 trials of other approaches did).
  • Among the 53 trials of exercise and physical activity found, none used clinical events, survival and healthcare use as a primary outcome (6 trials of other approaches did).
  • Among the 18 trials of breathing and respiratory training found, none used clinical events, survival and healthcare use as a primary outcome (6 trials of other approaches did).
  • Among the 17 trials of oxygen, light, temperature and manual therapies found, none used clinical events, survival and healthcare use as a primary outcome (6 trials of other approaches did).

Questions studied but with no results posted

  • Exercise and physical activity × physical function and exercise capacity: 29 trials registered, none with results posted (5 still recruiting)
  • Exercise and physical activity × heart rate, blood pressure and autonomic: 9 trials registered, none with results posted (2 still recruiting)
  • Breathing and respiratory training × physical function and exercise capacity: 9 trials registered, none with results posted
  • Oxygen, light, temperature and manual therapies × heart rate, blood pressure and autonomic: 9 trials registered, none with results posted
  • Rehabilitation and therapy services × physical function and exercise capacity: 8 trials registered, none with results posted (3 still recruiting)
  • Breathing and respiratory training × breathing and lung function: 5 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × quality of life: 4 trials registered, none with results posted
  • Exercise and physical activity × inflammation and other biomarkers: 3 trials registered, none with results posted
  • Breathing and respiratory training × heart rate, blood pressure and autonomic: 3 trials registered, none with results posted (3 still recruiting)
  • Supplements and nutraceuticals × physical function and exercise capacity: 3 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Pulmonary Arterial Hypertension

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 34 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.